 | Exhibitor Booth at the
American Society of Clincal Oncology (ASCO)
2007 Annual Meeting in Chicago, IL. |
ZIO-101 (S-dimethylarsino-glutathione):
Phase I/II Trials in Advanced/Progressive Multiple Myeloma
Presented at ASCO 2007
Click here to download the results of this study
A phase II trial of bortezomib + ascorbic acid + melphalan (BAM)
combination therapy for patients with newly diagnosed multiple myeloma
Presented at IMW 2007
Click here to download the results of this study
Phase I Trial of Bortezomib (Vel) and Samarium (Sam) in Multiple Myeloma
Presented at IMW 2007
Click here to download the results of this study
A phase II trial of bortezomib + ascorbic acid + melphalan (BAM)
combination therapy for patients with newly diagnosed multiple myeloma
Presented at ASH 2007
Click here to download the results of this study
A Phase I/II Trial of Zometa in Patients with
Monoclonal Gammopathy of Undetermined Significance
Presented at ASH 2007
Click here to download the results of this study
|
